ACADIA Pharmaceuticals, Inc. (ACAD) Management Discusses Q2 2013 Results (Webcast)

Aug. 6.13 | About: ACADIA Pharmaceuticals (ACAD)

ACADIA (ACAD): Q2 EPS of -$0.11 misses by $0.02. Revenue of $451K beats by $1K (PR)

The following audio is from an earnings conference call that will begin on August 6, 2013, at 5:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.